BioSpace News Archive

NESA MEDTECH RECEIVES U.S. FDA CLEARANCE FOR ITS FIBROID MAPPING REVIEWER APPLICATION (FMRA)

Nesa Medtech (Nesa), a private medical device company addressing clinical unmet needs for patients with symptomatic uterine fibroids, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s Fibroid Mapping Reviewer Application (FMRA).

July 24, 2023
·
2 min read
Drug Development

Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension

Keros Therapeutics announces U.S. Food and Drug Administration (“FDA”) has cleared its investigational new drug application to conduct a Phase 2 clinical trial of KER-012 in combination with background therapy in patients with pulmonary arterial hypertension.

July 24, 2023
·
5 min read
Business

Cognizant and Gilead Extend Partnership with Five-Year Service Agreement Estimated at $800 Million

Cognizant (NASDAQ: CTSH) today announced an expansion of its relationship with Gilead Sciences (NASDAQ: GILD). Gilead is a leading biopharmaceutical company advancing innovative medicines to prevent and treat life-threatening diseases.

July 24, 2023
·
6 min read